Große Auswahl an günstigen Büchern
Schnelle Lieferung per Post und DHL

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Über Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways forthe treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.

Mehr anzeigen
  • Sprache:
  • Englisch
  • ISBN:
  • 9789811575853
  • Einband:
  • Gebundene Ausgabe
  • Seitenzahl:
  • 228
  • Veröffentlicht:
  • 1. Oktober 2020
  • Ausgabe:
  • 12020
  • Abmessungen:
  • 155x235x0 mm.
  • Gewicht:
  • 580 g.
  Versandkostenfrei
  Versandfertig in 1-2 Wochen.
Verlängerte Rückgabefrist bis 31. Januar 2025

Beschreibung von Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways forthe treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.

Kund*innenbewertungen von Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models



Ähnliche Bücher finden
Das Buch Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models ist in den folgenden Kategorien erhältlich:

Willkommen bei den Tales Buchfreunden und -freundinnen

Jetzt zum Newsletter anmelden und tolle Angebote und Anregungen für Ihre nächste Lektüre erhalten.